INMODE LTD (INMD) Fundamental Analysis & Valuation

NASDAQ:INMD • IL0011595993

13.27 USD
-0.02 (-0.15%)
At close: Mar 10, 2026
13.2308 USD
-0.04 (-0.3%)
After Hours: 3/10/2026, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This INMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to INMD. INMD was compared to 184 industry peers in the Health Care Equipment & Supplies industry. INMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INMD has a bad growth rate and is valued cheaply. These ratings could make INMD a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. INMD Profitability Analysis

1.1 Basic Checks

  • INMD had positive earnings in the past year.
  • INMD had a positive operating cash flow in the past year.
  • Each year in the past 5 years INMD has been profitable.
  • Each year in the past 5 years INMD had a positive operating cash flow.
INMD Yearly Net Income VS EBIT VS OCF VS FCFINMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.24%, INMD belongs to the top of the industry, outperforming 92.93% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.73%, INMD belongs to the top of the industry, outperforming 88.59% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 10.44%, INMD belongs to the best of the industry, outperforming 89.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 9.15%.
  • The last Return On Invested Capital (10.44%) for INMD is well below the 3 year average (14.88%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROIC 10.44%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
INMD Yearly ROA, ROE, ROICINMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • INMD has a Profit Margin of 25.33%. This is amongst the best in the industry. INMD outperforms 96.20% of its industry peers.
  • INMD's Profit Margin has declined in the last couple of years.
  • INMD has a Operating Margin of 23.05%. This is amongst the best in the industry. INMD outperforms 94.57% of its industry peers.
  • INMD's Operating Margin has declined in the last couple of years.
  • INMD has a better Gross Margin (78.54%) than 91.85% of its industry peers.
  • INMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
INMD Yearly Profit, Operating, Gross MarginsINMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. INMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INMD is creating some value.
  • INMD has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INMD has been reduced compared to 5 years ago.
  • There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INMD Yearly Shares OutstandingINMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
INMD Yearly Total Debt VS Total AssetsINMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INMD has an Altman-Z score of 9.67. This indicates that INMD is financially healthy and has little risk of bankruptcy at the moment.
  • INMD's Altman-Z score of 9.67 is amongst the best of the industry. INMD outperforms 90.22% of its industry peers.
  • There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.67
ROIC/WACC1.22
WACC8.58%
INMD Yearly LT Debt VS Equity VS FCFINMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 9.88 indicates that INMD has no problem at all paying its short term obligations.
  • INMD's Current ratio of 9.88 is amongst the best of the industry. INMD outperforms 91.85% of its industry peers.
  • INMD has a Quick Ratio of 8.83. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of INMD (8.83) is better than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 9.88
Quick Ratio 8.83
INMD Yearly Current Assets VS Current LiabilitesINMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. INMD Growth Analysis

3.1 Past

  • INMD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.99%.
  • The Earnings Per Share has been growing by 8.96% on average over the past years. This is quite good.
  • The Revenue has decreased by -6.16% in the past year.
  • INMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.45% yearly.
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.48% on average over the next years.
  • The Revenue is expected to grow by 1.82% on average over the next years.
EPS Next Y-8.96%
EPS Next 2Y-1.65%
EPS Next 3Y1.48%
EPS Next 5YN/A
Revenue Next Year-0.3%
Revenue Next 2Y1.82%
Revenue Next 3Y1.82%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INMD Yearly Revenue VS EstimatesINMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
INMD Yearly EPS VS EstimatesINMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. INMD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.19, the valuation of INMD can be described as very reasonable.
  • INMD's Price/Earnings ratio is rather cheap when compared to the industry. INMD is cheaper than 95.65% of the companies in the same industry.
  • INMD is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • INMD is valuated reasonably with a Price/Forward Earnings ratio of 9.00.
  • Based on the Price/Forward Earnings ratio, INMD is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of INMD to the average of the S&P500 Index (24.39), we can say INMD is valued rather cheaply.
Industry RankSector Rank
PE 8.19
Fwd PE 9
INMD Price Earnings VS Forward Price EarningsINMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INMD is valued cheaply inside the industry as 99.46% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, INMD is valued cheaply inside the industry as 98.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.98
EV/EBITDA 2.36
INMD Per share dataINMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The excellent profitability rating of INMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2Y-1.65%
EPS Next 3Y1.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INMD Dividend Analysis

5.1 Amount

  • INMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INMD Fundamentals: All Metrics, Ratios and Statistics

INMODE LTD

NASDAQ:INMD (3/10/2026, 8:00:03 PM)

After market: 13.2308 -0.04 (-0.3%)

13.27

-0.02 (-0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-27
Inst Owners56.66%
Inst Owner Change-3.29%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap840.79M
Revenue(TTM)370.50M
Net Income(TTM)93.83M
Analysts74.29
Price Target17.14 (29.16%)
Short Float %5.89%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.57%
Min EPS beat(2)5.11%
Max EPS beat(2)8.04%
EPS beat(4)3
Avg EPS beat(4)2.52%
Min EPS beat(4)-13.69%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-4.69%
EPS beat(12)7
Avg EPS beat(12)-1.79%
EPS beat(16)11
Avg EPS beat(16)1.34%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.72%
Revenue beat(12)4
Avg Revenue beat(12)-4.28%
Revenue beat(16)8
Avg Revenue beat(16)-2.02%
PT rev (1m)1.2%
PT rev (3m)0%
EPS NQ rev (1m)-11.49%
EPS NQ rev (3m)-12.36%
EPS NY rev (1m)-12.23%
EPS NY rev (3m)-12.96%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-2.63%
Revenue NY rev (1m)-3.52%
Revenue NY rev (3m)-3.92%
Valuation
Industry RankSector Rank
PE 8.19
Fwd PE 9
P/S 2.27
P/FCF 9.98
P/OCF 9.86
P/B 1.23
P/tB 1.23
EV/EBITDA 2.36
EPS(TTM)1.62
EY12.21%
EPS(NY)1.47
Fwd EY11.11%
FCF(TTM)1.33
FCFY10.02%
OCF(TTM)1.35
OCFY10.14%
SpS5.85
BVpS10.78
TBVpS10.78
PEG (NY)N/A
PEG (5Y)0.91
Graham Number19.83
Profitability
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROCE 12.27%
ROIC 10.44%
ROICexc 51.74%
ROICexgc 51.74%
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
FCFM 22.75%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
ROICexc(3y)140.37%
ROICexc(5y)572.43%
ROICexgc(3y)140.37%
ROICexgc(5y)572.43%
ROCE(3y)17.49%
ROCE(5y)25.39%
ROICexgc growth 3Y-64.14%
ROICexgc growth 5Y-69.81%
ROICexc growth 3Y-64.14%
ROICexc growth 5Y-69.81%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 139.86%
Cap/Sales 0.26%
Interest Coverage 250
Cash Conversion 99.04%
Profit Quality 89.83%
Current Ratio 9.88
Quick Ratio 8.83
Altman-Z 9.67
F-Score4
WACC8.58%
ROIC/WACC1.22
Cap/Depr(3y)114.97%
Cap/Depr(5y)150.7%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.24%
Profit Quality(3y)83.88%
Profit Quality(5y)93.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
EPS Next Y-8.96%
EPS Next 2Y-1.65%
EPS Next 3Y1.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%
Revenue Next Year-0.3%
Revenue Next 2Y1.82%
Revenue Next 3Y1.82%
Revenue Next 5YN/A
EBIT growth 1Y-23.82%
EBIT growth 3Y-24.44%
EBIT growth 5Y3.24%
EBIT Next Year-6.64%
EBIT Next 3Y1.31%
EBIT Next 5YN/A
FCF growth 1Y-36.15%
FCF growth 3Y-22.35%
FCF growth 5Y1.38%
OCF growth 1Y-35.73%
OCF growth 3Y-22.28%
OCF growth 5Y1.48%

INMODE LTD / INMD FAQ

Can you provide the ChartMill fundamental rating for INMODE LTD?

ChartMill assigns a fundamental rating of 7 / 10 to INMD.


Can you provide the valuation status for INMODE LTD?

ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.


How profitable is INMODE LTD (INMD) stock?

INMODE LTD (INMD) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for INMD stock?

The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 8.19 and the Price/Book (PB) ratio is 1.23.